(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)

C74H80F6N10O16 — CID 158437820

IUPAC(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)
SMILESO=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21
InChIInChI=1S/2C35H39N5O6.2C2HF3O2/c41-31(20-24-10-5-2-6-11-24)38-28-15-13-27-14-16-30(40(27)35(28)46)34(45)39-29(19-25-12-7-17-36-22-25)33(44)37-26(21-32(42)43)18-23-8-3-1-4-9-23;41-31(21-24-9-5-2-6-10-24)38-28-13-11-27-12-14-30(40(27)35(28)46)34(45)39-29(20-25-15-17-36-18-16-25)33(44)37-26(22-32(42)43)19-23-7-3-1-4-8-23;2*3-2(4,5)1(6)7/h1-12,17,22,26-30H,13-16,18-21H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);1-10,15-18,26-30H,11-14,19-22H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);2*(H,6,7)/t2*26-,27-,28?,29-,30-;;/m00../s1
InChIKeyVKMSQUVYKPOCBM-GEXDSPQGSA-N
MW1479.50 g/mol
LogP5.65
Rot. Bonds26

About (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)

(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) (PubChem CID 158437820) has the molecular formula C74H80F6N10O16 and a molecular weight of 1479.50 g/mol. Its IUPAC name is (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid).

Molecular Properties

Compound Name(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)
PubChem CID158437820
Molecular FormulaC74H80F6N10O16
Molecular Weight1479.50 g/mol
Exact Mass1478.57
IUPAC Name(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)
SMILESO=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21
InChIInChI=1S/2C35H39N5O6.2C2HF3O2/c41-31(20-24-10-5-2-6-11-24)38-28-15-13-27-14-16-30(40(27)35(28)46)34(45)39-29(19-25-12-7-17-36-22-25)33(44)37-26(21-32(42)43)18-23-8-3-1-4-9-23;41-31(21-24-9-5-2-6-10-24)38-28-13-11-27-12-14-30(40(27)35(28)46)34(45)39-29(20-25-15-17-36-18-16-25)33(44)37-26(22-32(42)43)19-23-7-3-1-4-8-23;2*3-2(4,5)1(6)7/h1-12,17,22,26-30H,13-16,18-21H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);1-10,15-18,26-30H,11-14,19-22H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);2*(H,6,7)/t2*26-,27-,28?,29-,30-;;/m00../s1
InChIKeyVKMSQUVYKPOCBM-GEXDSPQGSA-N
XLogP5.65
TPSA390.20 Ų
H-Bond Donors10
H-Bond Acceptors14
Rotatable Bonds26
Heavy Atoms106
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001479.50
LogP ≤ 55.65
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1014

Analyze (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)?
The IUPAC name of (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) (CID 158437820) is (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid).
What is the SMILES notation for (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)?
The canonical SMILES for (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) is O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cccnc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21.O=C(O)C[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccncc1)NC(=O)[C@@H]1CC[C@@H]2CCC(NC(=O)Cc3ccccc3)C(=O)N21.
What is the InChIKey of (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)?
The InChIKey is VKMSQUVYKPOCBM-GEXDSPQGSA-N. The full InChI is InChI=1S/2C35H39N5O6.2C2HF3O2/c41-31(20-24-10-5-2-6-11-24)38-28-15-13-27-14-16-30(40(27)35(28)46)34(45)39-29(19-25-12-7-17-36-22-25)33(44)37-26(21-32(42)43)18-23-8-3-1-4-9-23;41-31(21-24-9-5-2-6-10-24)38-28-13-11-27-12-14-30(40(27)35(28)46)34(45)39-29(20-25-15-17-36-18-16-25)33(44)37-26(22-32(42)43)19-23-7-3-1-4-8-23;2*3-2(4,5)1(6)7/h1-12,17,22,26-30H,13-16,18-21H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);1-10,15-18,26-30H,11-14,19-22H2,(H,37,44)(H,38,41)(H,39,45)(H,42,43);2*(H,6,7)/t2*26-,27-,28?,29-,30-;;/m00../s1.
What are the key properties of (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid)?
(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) has a molecular weight of 1479.50 g/mol, XLogP of 5.65, 26 rotatable bonds, 10 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-3-ylpropanoyl]amino]-4-phenylbutanoic acid;(3S)-3-[[(2S)-2-[[(3S,8aS)-5-oxo-6-[(2-phenylacetyl)amino]-2,3,6,7,8,8a-hexahydro-1H-indolizine-3-carbonyl]amino]-3-pyridin-4-ylpropanoyl]amino]-4-phenylbutanoic acid;bis(2,2,2-trifluoroacetic acid) is sourced from PubChem (CID 158437820), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).